2021
DOI: 10.3390/molecules26113093
|View full text |Cite
|
Sign up to set email alerts
|

Recent Progress in Transdermal Nanocarriers and Their Surface Modifications

Abstract: Transdermal drug delivery system (TDDS) is an attractive method for drug delivery with convenient application, less first-pass effect, and fewer systemic side effects. Among all generations of TDDS, transdermal nanocarriers show the greatest clinical potential because of their non-invasive properties and high drug delivery efficiency. However, it is still difficult to design optimal transdermal nanocarriers to overcome the skin barrier, control drug release, and achieve targeting. Hence, surface modification b… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
26
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 25 publications
(29 citation statements)
references
References 73 publications
0
26
0
Order By: Relevance
“…Stability of drug-loaded formulation, frequent dosing schedules, and difficult manufacturing processes raise the need for developing topical formulations than oral ACE formulations. Recently, lipid-based nanocarriers have emerged as a promising tool for transdermal delivery through different methods, such as nanoemulsions ( Modi and Patel, 2011 ), SLNs ( Jain et al, 2014 ), and NLCs ( Hung et al, 2011 ) via engineering, the precision of which is based on nanotechnological advances ( Chawla and Saraf, 2012 ) for drug delivery to enhance personalized interventions ( Carbone et al, 2013 ; Yu Z. et al, 2021 ; Mitchell et al, 2021 ).…”
Section: Introductionmentioning
confidence: 99%
“…Stability of drug-loaded formulation, frequent dosing schedules, and difficult manufacturing processes raise the need for developing topical formulations than oral ACE formulations. Recently, lipid-based nanocarriers have emerged as a promising tool for transdermal delivery through different methods, such as nanoemulsions ( Modi and Patel, 2011 ), SLNs ( Jain et al, 2014 ), and NLCs ( Hung et al, 2011 ) via engineering, the precision of which is based on nanotechnological advances ( Chawla and Saraf, 2012 ) for drug delivery to enhance personalized interventions ( Carbone et al, 2013 ; Yu Z. et al, 2021 ; Mitchell et al, 2021 ).…”
Section: Introductionmentioning
confidence: 99%
“…Transdermal delivery, as opposed to typical oral and subcutaneous injections, avoids the liver’s first-pass action and is less invasive, painless, and cost-effective [ 109 ]. Drug encapsulation and release affect transdermal drug delivery, which is currently used in the treatment of numerous skin illnesses such as psoriasis, contact dermatitis, and skin cancer [ 110 ].…”
Section: Drug Release Methods Of the Polymer Nanofibers-based Ddsmentioning
confidence: 99%
“…Still, nanosystems that do not [exclusively] derive from natural lipids have been thoroughly explored for percutaneous permeation of bioactive molecules; organic nanoformulations comprising either natural or synthetic polymers and/or surfactants other than natural lipids can be found in recent literature, covering distinct types of dendrimers, nanoparticles (NPs), nanoemulsions (NEs), micelles, and hydrogels, for diverse purposes. Likewise, inorganic nanosystems, including metallic, non-metallic, and magnetic NPs, among others, have been employed for DTD of [bio]pharmaceuticals [ 42 , 44 ].…”
Section: Overview Of Current Methods For Dermal and Transdermal Drug Deliverymentioning
confidence: 99%